Deep Intelligent Pharma
PrivateLast Round
VC Round
Feb 2, 2026
Total Funding Raised
$105M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Deep Intelligent Pharma is a healthcare technology company that provides an AI-native platform to automate and optimize clinical trials for the pharmaceutical and biotech industries.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Medical AI, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deep Intelligent Pharma Comparables
Compare Deep Intelligent Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlphaLife Sciences | 81% | |
| Risklick AG | 71% | |
| AIRA Health | 71% |
Deep Intelligent Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 2, 2026 | ||||
| Series D | Dec 11, 2025 | ||||
| Series D | Jan 19, 2024 | ||||
| Series B | Oct 9, 2018 |
Deep Intelligent Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Baifu | Series D |
| Kaitai Capital | Series D, VC Round |
| Trustar Capital | VC Round |
| Xin Ding Capital | Series D, VC Round |
| CDH Investments | VC Round |
| HongShan Capital Group (HSG) | Series D, Series B |
| JinYi Capital | Series D, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 310, 1240% of current headcount.
- Feb 25, 2026
Grew 22% QoQ, from 18 to 22 employees.
Deep Intelligent Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Deep Intelligent Pharma's valuation, stock price, and market status.
Is Deep Intelligent Pharma a public or private company?
Deep Intelligent Pharma is a private company.
What is the current stock price of Deep Intelligent Pharma?
Deep Intelligent Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Deep Intelligent Pharma worth (valuation)?
Valuation information for Deep Intelligent Pharma is not publicly available.
Can I buy Deep Intelligent Pharma stock?
Deep Intelligent Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Deep Intelligent Pharma's last funding round?
Deep Intelligent Pharma's most recent funding round was VC Round on February 2, 2026.
Who are the main investors in Deep Intelligent Pharma?
Key investors in Deep Intelligent Pharma include CDH Baifu, Trustar Capital, HongShan.
Will Deep Intelligent Pharma IPO soon?
No public IPO plans have been announced for Deep Intelligent Pharma.
How can I track Deep Intelligent Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Deep Intelligent Pharma's secondary market activity and sign up for updates.